Neurosign

Neurosign is a specialized medical technology company that develops intraoperative nerve monitoring (IONM) systems for surgical use. The company's primary mission is to provide surgeons with the tools necessary to identify, map, and monitor motor nerves during complex procedures, thereby reducing the risk of post-operative nerve damage. Its flagship product, the V4 Nerve Monitor, is widely recognized for its precision in ENT, endocrine, and neurosurgical applications. In addition to hardware, Neurosign offers a comprehensive range of electrodes and stimulating probes tailored for various surgical environments. Originally a division of The Magstim Company, Neurosign was acquired by Technomed in 2022, integrating its expertise into a broader neurophysiology portfolio. The company maintains a global presence, serving hospitals and surgical centers through an extensive distribution network.